Hahn Urges Fixed Terms For US FDA Leaders

US COVID-19 response
Stephen Hahn said in the interview that decisions on hydroxychloroquine were correct at the time they were made. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet